ALL06 A Phase II trial of an intensive pediatric protocol incorporating post-induction stratification based on minimal residual disease levels for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed acute lymphoblastic leukaemia (ALL)
收藏数据链接：
官方服务：
资源简介：
HeSANDA 1.0.0
创建时间：
2023-05-31
